CMC Requirements for New Drug Registration in Latin America
ISPE
MAY 9, 2023
However, existing, or new local regulatory requirements still present hurdles and the regulators’ intention to embrace ICH guidelines or to accept alternate risk-based, scientifically supported approaches may be interpreted negatively by global pharmaceutical companies. 1 a b Brazilian Health Regulatory Agency (Anvisa), Ministry of Health.
52 
Let's personalize your content